Duvall Diantha

CIK 00016967843 companiesLEXINGTON, MA

SEC Profile

Transactions

Companies

Filings

CIK

0001696784

Recent Transactions

46 trades

Conversion
CURIS INC$CRIS
Common Stock
2026-03-20+66,666→ 77,707 total
Conversion
CURIS INC$CRIS
Series B Convertible Preferred Stock
2026-03-20−50→ 0 total
Award
CURIS INC$CRIS
Series B Warrant (right to buy)
2026-03-17+66,666→ 66,666 total
Award
CURIS INC$CRIS
Series C Warrant (right to buy)
2026-03-17+66,666→ 66,666 total
Award
CURIS INC$CRIS
Series A Warrant (right to buy)
2026-03-17+66,666→ 66,666 total
Award
CURIS INC$CRIS
Series B Convertible Preferred Stock
2026-03-17+50→ 50 total
Award
CURIS INC$CRIS
Employee stock option (right to buy)
2025-05-20$3.13/sh+135,000→ 135,000 total
Award
CURIS INC$CRIS
Employee stock option (right to buy)
2025-01-28$3.13/sh+15,000→ 15,000 total
Award
CURIS INC$CRIS
Employee stock option (right to buy)
2024-05-21$11.62/sh+39,000→ 39,000 total
Award
CURIS INC$CRIS
Employee stock option (right to buy)
2023-01-20+500,000→ 500,000 total
Sale
GENOCEA BIOSCIENCES, INC.
Common Stock
2022-06-02$0.06/sh−1,355→ 75,388 total
Sale
GENOCEA BIOSCIENCES, INC.
Common Stock
2022-05-26$0.08/sh−24,407→ 76,743 total
Sale
GENOCEA BIOSCIENCES, INC.
Common Stock
2022-04-04$1.25/sh−963→ 91,775 total
Sale
GENOCEA BIOSCIENCES, INC.
Common Stock
2022-03-16$1.10/sh−2,873→ 92,738 total
Award
GENOCEA BIOSCIENCES, INC.
Common Stock
2022-03-15+37,500→ 95,611 total
Award
GENOCEA BIOSCIENCES, INC.
Stock Option (Right to Buy)
2022-03-15+112,500→ 112,500 total
Sale
GENOCEA BIOSCIENCES, INC.
Common Stock
2021-06-01$2.23/sh−511→ 62,486 total
Sale
GENOCEA BIOSCIENCES, INC.
Common Stock
2021-04-02$2.71/sh−925→ 62,997 total
Award
GENOCEA BIOSCIENCES, INC.
Stock Option (Right to Buy)
2021-03-15+112,500→ 112,500 total
Award
GENOCEA BIOSCIENCES, INC.
Common Stock
2021-03-15+37,500→ 37,500 total
Award
GENOCEA BIOSCIENCES, INC.
Restricted Stock Unit
2021-03-15+100,000→ 100,000 total
Award
GENOCEA BIOSCIENCES, INC.
Stock Option (Right to Buy)
2020-06-01+24,938→ 24,938 total
Award
GENOCEA BIOSCIENCES, INC.
Common Stock
2020-06-01+6,623→ 6,623 total
Award
GENOCEA BIOSCIENCES, INC.
Stock Option (Right to Buy)
2020-04-02+46,313→ 46,313 total
Award
GENOCEA BIOSCIENCES, INC.
Common Stock
2020-04-02+12,299→ 12,299 total
Award
GENOCEA BIOSCIENCES, INC.
Stock Option (Right to Buy)
2019-03-05+475,000→ 475,000 total
Disposition to Issuer
Bioverativ Inc.
Restricted Stock Units
2018-03-08−7,273→ 0 total
Disposition to Issuer
Bioverativ Inc.
Non-Qualified Stock Option
2018-03-08−7,030→ 0 total
Disposition to Issuer
Bioverativ Inc.
Non-Qualified Stock Option
2018-03-08−11,062→ 0 total
Disposition to Issuer
Bioverativ Inc.
Common Stock
2018-03-08−2,791→ 0 total
Disposition to Issuer
Bioverativ Inc.
Restricted Stock Units
2018-03-08−2,780→ 0 total
Tax Payment
Bioverativ Inc.
Common Stock
2018-03-02$104.73/sh−105→ 2,791 total
Tax Payment
Bioverativ Inc.
Common Stock
2018-02-22$104.30/sh−168→ 2,896 total
Exercise/Conversion
Bioverativ Inc.
Common Stock
2018-02-14+1,390→ 3,518 total
Tax Payment
Bioverativ Inc.
Common Stock
2018-02-14$103.52/sh−454→ 3,064 total
Exercise/Conversion
Bioverativ Inc.
Restricted Stock Units
2018-02-14−1,390→ 2,780 total
Award
Bioverativ Inc.
Restricted Stock Units
2018-01-31+7,273→ 7,273 total
Sale
Bioverativ Inc.
Common Stock
2017-06-28$60.47/sh−818→ 2,128 total
Tax Payment
Bioverativ Inc.
Common Stock
2017-05-02$57.48/sh−99→ 2,946 total
Tax Payment
Bioverativ Inc.
Common Stock
2017-03-02$52.81/sh−113→ 3,045 total
Award
Bioverativ Inc.
Common Stock
2017-02-28+3,360→ 3,369 total
Award
Bioverativ Inc.
Non-Qualified Stock Option
2017-02-28+7,030→ 7,030 total
Tax Payment
Bioverativ Inc.
Common Stock
2017-02-28$47.76/sh−211→ 3,158 total
Award
Bioverativ Inc.
Restricted Stock Units
2017-02-14+4,170→ 4,170 total
Award
Bioverativ Inc.
Non-Qualified Stock Option
2017-02-14+11,062→ 11,062 total
Award
Bioverativ Inc.
Non-Qualified Stock Option
2017-02-14+11,043→ 11,043 total

Companies

Recent Filings

Address

128 SPRING STREET BUILDING C - SUITE 500

LEXINGTON, MA, 02421

View on SEC.gov